Thierer Mark 4
4 · XERIS PHARMACEUTICALS INC · Filed Oct 2, 2019
Insider Transaction Report
Form 4
Thierer Mark
Director
Transactions
- Award
Stock Option (right to buy)
2019-09-30+19,650→ 19,650 totalExercise: $9.83Exp: 2029-09-30→ Common Stock (19,650 underlying)
Footnotes (1)
- [F1]The options will vest monthly over three years, subject to continued service as a director through such vesting date.